Science and Enterprise

Tag: biotechnology

  • Investor Company to Offer Cancer Therapy Development Funding

    Mentor Capital Inc. in San Diego, California plans to extend its funding beyond cancer immunotherapy — its current specialty — to other leading cancer solutions. Its objective is to provide investments that fill the gap for therapies between initial lab development and their acquisition by major pharmaceutical companies. This middle stage is often called “The…

  • Biotech Inks Three New Drug Discovery Deals

    Adimab Inc., a biotechnology company in Lebanon, New Hampshire today announced three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. The company offers a technology platform for the discovery of human antibodies. For Eli Lilly, Adimab will use its discovery platform to identify fully human antibodies against two targets selected by…

  • Fund Established to Develop Cancer Vaccines

    Cancer Research Institute (CRI) a not-for-profit organization in New York to advance the science of tumor immunology and discover new cancer therapies, launched today the Cancer Vaccine Acceleration Fund (CVAF), a new model of philanthropic investment and academic-industry collaboration. CRI established the fund with the Ludwig Institute for Cancer Research to encourage development of therapeutic…

  • Biotech Gets DARPA Grant for Respiratory Therapies

    Pulmatrix, a biotechnology company in Lexington, Massachusetts, said today it received a grant for $5.7 million from the Defense Advanced Research Projects Agency (DARPA) in the Department of Defense, to further develop the company’s processes for the treatment and prevention of respiratory infections. DARPA identified Pulmatrix’s inhaled cationic airway lining modulators (iCALM) technology as a…

  • U.S. Biotech, Japanese Pharma Partner on Protein Drugs

    Anaphore Inc. of La Jolla, California and Mitsubishi Tanabe Pharma Corporation in Osaka, Japan formed a partnership for research, development, and commercialization of protein therapies for autoimmune disease. The partnership will focus on disorders such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. The companies will make use of Anaphore’s technology, which generates novel trivalent…

  • Company Leads Consortium to Crystallize Parkinson’s Enzyme

    Emerald BioStructures, a structural biology services company in Bainbridge Island, Washington, received a grant to lead a consortium to crystallize and solve the structure of the enzyme believed to be a key molecular mechanism behind Parkinson’s disease. The project, funded by the Michael J. Fox Foundation for Parkinson’s Research, includes researchers from the Helmholtz Association…

  • U.K. Lab Spin Off Creates Athletic Testing Device

    UK Sport, the national development organization for elite athletes in the U.K., has agreed to use a new hand-held medical device to help improve athletes’ training programs. The device is made by Argento Diagnostics, a company spun off fron the National Physical Laboratory, the country’s national institute for standards and measurements. The Argento Diagnostics device…

  • Laser Developed for Stem Cell Research

    Hamilton Thorne Ltd., a developer of laser-based instruments in Beverly, Massachusetts, unveiled today its Stiletto laser system for stem cell researchers. The company says the Stiletto is designed to automate slow, manual processes of separating and removing unwanted cells, which can help researchers reduce cell selection time from hours to seconds. According to Hamilton Thorne,…

  • Univ. Tests Ultrasound to Diagnose Prostate Cancer

    Researchers at Eindhoven University of Technology (TU/e) in the Netherlands, with Academic Medical Center Amsterdam, have developed and conducted early tests on an imaging technology that can accurately identify prostate cancer tumors. The technology is based on ultrasound, and also has the potential to assess how aggressive tumors are. A number of ultrasound companies are…

  • Disposable Insulin Device Gets FDA Clearance

    Valeritas Inc., a medical technology company in Bridgewater, New Jersey, says that the US Food and Drug Administration (FDA) has granted 510(k) clearance to the company’s V-Go disposable insulin delivery device. The company designed V-Go for the subcutaneous delivery of insulin in preset basal (low continuous) rates and with on-demand bolus (high volume) dosing for…